Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 7—July 2003

Disease Surveillance and the Academic, Clinical, and Public Health Communities

Robert W. Pinner*Comments to Author , Catherine A. Rebmann*, Anne Schuchat*, and James M. Hughes*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 2

Infectious causes and explanations for unexplained deaths and critical illnesses cases, 1995–1998, California, Oregon, Connecticut, and Minnesota (n=34)a,b

Syndrome Etiology (n) Tests (n)
Neurologic (n=15)
Neisseria meningitidis (4)
16S rDNA PCR (2), PCR (1), EIA IgM (1)a
Bartonella hensaelae (1)
Bartonella spp. (2)
Chlamydia pneumoniae (1)
Mycoplasma pneumoniae (1)
Cytomegalovirus (1)
Coxsackie B (1)
EIA,IgM, viral culture
Enterovirus (1)
Epstein-Barr virus (1)
IFA,IgG (VCA and EA)
Human herpes virus 6 (1)
IFA and EIA (IgM and IgG)
Mumps virus (1)
Respiratory (n=13)
Chlamydia pneumoniae (2)
MIF IgG (2), IFA, IgM
Mycoplasma pneumoniae (4)
                    PCR (blood), EIA, IgM/IgG
Streptococcus pneumoniae (2)
16S rDNA PCR (pleural fluid)
Legionella spp. (1)
PCR (from lung)
Adenovirus (1)
EIA and IFA, IgG
Influenza B virus (1)
                    EIA and IFA, IgG
Influenza A virus (1)
EIA and IFA, IgM, EIA (IgG)
Human parainfluenza virus types 1 and 3 (1)
EIA and IFA, IgG
Cardiac (n=3)
Borrelia burgdorferi/Ehrlichia chaffeensis (1)
                    EIA/IFA flagella, IgG, Western Blot (IgG and IgM)
Enterovirus (1)
Legionella spp. (1)
                    PCR (heart)
Multisystem (n=3) Neisseria meningitidis (1)
PCR (cerebrospinal fluid)
Adenovirus (1)
PCR (blood)
Enterovirus (1) IgM, EIA

a PCR, polymerase chain reaction; EIA, enzyme immunosorbent assay; IFA, indirect immunofluorescent assay; IG, immunoglobulin; MIF, microimmunofluorescence.

bReference 12.

Main Article

  1. Gerberding  JL, Hughes  JM, Koplan  JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. JAMA. 2002;287:89890. DOIPubMedGoogle Scholar
  2. Petersen  LR, Marfin  AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:1739.PubMedGoogle Scholar
  3. Centers for Disease Control and Prevention. West Nile virus activity—United States, September 26–October 2, 2002, and investigations of West Nile virus infections in recipients of blood transfusion and organ transplantation. MMWR Morb Mortal Wkly Rep 2002;51:884,895.
  4. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington: National Academy Press; 1992.
  5. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 1994.
  6. Centers for Disease Control and Prevention. Preventing emerging infectious diseases: a strategy for the 21st Century. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 1998.
  7. Hardnett  FP, Hoekstra  RM, Kennedy  MH, Angulo  FJ; EIP Foodnet Working Group. Comparability of FoodNet and United States populations. Poster presented at: International Conference on Emerging Infectious Diseases; 24–27 March 2002; Atlanta, Ga.
  8. Schuchat  A, Hilger  T, Zell  E, Farley  MM, Reingold  A, Harrison  L, Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis. 2001;7:929. DOIPubMedGoogle Scholar
  9. Centers for Disease Control and Prevention. Foodborne diseases active surveillance network. MMWR Morb Mortal Wkly Rep. 1997;46:25861.PubMedGoogle Scholar
  10. Herikstad  H, Yang  S, Van Gilder  TJ, Vugia  D, Hadler  J, Blake  P, A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996–7. Epidemiol Infect. 2002;129:917. DOIPubMedGoogle Scholar
  11. Mead  PS, Slutsker  L, Dietz  V, McCaig  LF, Bresee  JS, Shapiro  C, Food-related illness and death in the United States. Emerg Infect Dis. 1999;5:60725. DOIPubMedGoogle Scholar
  12. Hajjeh  RA, Relman  D, Cieslak  PR, Sofair  AN, Passaro  D, Flood  J, Surveillance for unexplained deaths and critical illnesses due to possibly infectious cases, United States, 1995–1998. Emerg Infect Dis. 2002;8:14553. DOIPubMedGoogle Scholar
  13. Perkins  BA, Flood  JM, Danila  R, Holman  RC, Reingold  AL, Klug  LA, Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. Emerg Infect Dis. 1996;2:4753. DOIPubMedGoogle Scholar
  14. Ijdo  JW, Meek  JI, Cartter  ML, Magnarelli  LA, Wu  C, Tenuta  SW, Emergence of another tickborne infection in the 12-town area around Lyme, CT: human ehrlichiosis. J Infect Dis. 2000;181:138893. DOIPubMedGoogle Scholar
  15. Centers for Disease Control and Prevention. Surveillance for Creutzfeldt-Jakob disease—United States. MMWR Morb Mortal Wkly Rep. 1996;45:6658.PubMedGoogle Scholar
  16. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2000;49(RR-9):135.PubMedGoogle Scholar
  17. Robinson  KA, Baughman  W, Rothrock  G, Barrett  NL, Pass  M, Lexau  C, Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285:172935. DOIPubMedGoogle Scholar
  18. Centers for Disease Control and Prevention. Notice to readers: decreasing availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2001;50:783.
  19. Whitney  CG, Farley  MM, Hadler  J, Harrison  LH, Bennet  NM, Lynfield  R, Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:173746. DOIPubMedGoogle Scholar
  20. Whitney  CG, Farley  MM, Hadler  J, Harrison  LH, Lexau  C, Reingold  A, Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:191724. DOIPubMedGoogle Scholar
  21. Heffelfinger  JD, Dowell  SF, Jorgensen  JH, Klugman  KP, Mabry  LR, Musher  DM, Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the drug-resistant Pneumococcus pneumonia therapeutic working group. Arch Intern Med. 2000;160:1399408. DOIPubMedGoogle Scholar
  22. Schrag  SJ, Zywicki  S, Farley  M, Reingold  A, Harrison  L, Lefkowitz  L, Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis: population-based surveillance in the United States, 1993–1998. N Engl J Med. 2000;342:1520. DOIPubMedGoogle Scholar
  23. Centers for Disease Control and Prevention. Early-onset group B streptococcal disease-United States, 1998–1999. MMWR Morb Mortal Wkly Rep. 2000;49:7936.
  24. Schrag  SJ, Zell  ER, Lynfield  R, Roome  A, Arnold  KE, Craig  AS, A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347:2339. DOIPubMedGoogle Scholar
  25. Schrag  S, Gorwitz  R, Fultz-Butts  K, Schuchat  A. Prevention of perinatal group B streptococcal disease. Revised guidelines from the CDC. MMWR Morb Mortal Wkly Rep. 2002;51(RR-11):122.PubMedGoogle Scholar
  26. Hyde  TB, Hilger  TM, Reingold  A, Farley  MM, O’Brien  KL, Schuchat  A. Trends in the incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110:6905. DOIPubMedGoogle Scholar
  27. Baltimore  RS, Huie  SM, Meek  JI, Schuchat  A, O’Brien  KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics. 2001;108:10948. DOIPubMedGoogle Scholar
  28. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne illnesses—select sites, United States, 2001. MMWR Morb Mortal Wkly Rep. 2002;51:3259.PubMedGoogle Scholar
  29. Centers for Disease Control and Prevention. Diagnosis and management of foodborne illnesses. MMWR Morb Mortal Wkly Rep. 2001;50(RR-2):169.PubMedGoogle Scholar
  30. Duchin  JS, Koster  FT, Peters  CJ, Simpson  GL, Tempest  B, Zaki  SR, Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med. 1994;331:5468.PubMedGoogle Scholar
  31. Zaki  SR, Khan  AS, Goodman  RA, Armstrong  LR, Greer  PW, Coffield  LM, Retrospective diagnosis of hantavirus pulmonary syndrome, 1978–1993: implications for emerging infectious diseases. Arch Pathol Lab Med. 1996;120:1349.PubMedGoogle Scholar
  32. Park  SY, Glaser  C, Murray  WJ, Kazacos  KR, Rowley  HA, Frederick  DR, Raccoon roundworm (Baylisascaris procyonis) encephalitis: case report and field investigation. Pediatrics. 2000;106:e56. DOIPubMedGoogle Scholar
  33. Asnis  DS, Conetta  R, Teixeira  AA, Waldman  G, Sampson  BA. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis. 2000;30:4138. DOIPubMedGoogle Scholar
  34. Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness among injecting drug users—Scotland, Ireland, and England, April–June 2000. MMWR Morb Mortal Wkly Rep. 2000;49:5435.PubMedGoogle Scholar

Main Article

Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.